Skip to main content
Log in

Body mass index is associated with prognosis in Japanese elderly patients with atrial fibrillation: an observational study from the outpatient clinic

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

The relationship between body mass index (BMI) and the prognosis of elderly patients with atrial fibrillation (AF) is unknown. We aimed to examine the association of body weight with the clinical outcomes among Japanese elderly patients with a history of documented AF. This observational study of AF patients from an outpatients clinic in Nagoya University Hospital included 413 patients ≥70 years old (99 obese: BMI ≥25 kg/m2; 256 normal weight: BMI 18.5–24.9 kg/m2; and 58 underweight patients: BMI <18.5 kg/m2). The mean age was 77.5 ± 5.6 years. During a mean follow-up of 19.0 months, all-cause death occurred in 23 patients (obese 1 %, normal weight 5.1 %, and underweight 16 %). The major adverse events including all-cause death, stroke or transient ischemic attack, heart failure requiring admission, and acute coronary syndrome were observed in 53 patients (obese 5.1 %, normal weight 13 %, and underweight 26 %). After adjusting for confounding factors, the underweight group had a significantly greater risk for all-cause death [hazard ratio (HR) 2.91, 95 % confidence interval (CI) 1.12–7.60, p = 0.029], and major adverse events (HR 2.45, 95 % CI 1.25–4.78, p = 0.009) than the normal weight group. In contrast, the obese group had a better prognosis in major adverse events compared with the normal weight group (HR 0.34, 95 % CI 0.13–0.89, p = 0.029). In conclusion, lower BMI was independently associated with poor outcomes among older AF patients. The association between obesity and better prognosis in elderly AF patients was also found.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD, Investigators CHARM (2007) Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 116:627–636

    Article  PubMed  Google Scholar 

  2. Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A, GREAT (Global Research on Acute Conditions Team) Network (2014) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63:778–785

    Article  PubMed  Google Scholar 

  3. Potapov EV, Loebe M, Anker S, Stein J, Bondy S, Nasseri BA, Sodian R, Hausmann H, Hetzer R (2003) Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 24:1933–1941

    Article  PubMed  Google Scholar 

  4. Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Negoita M, Lansky AJ, Mehran R (2006) Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 151:168–175

    Article  PubMed  Google Scholar 

  5. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Yokota T, Goto K, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H, Investigators JCARE-CARD (2010) Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. Circ J 74:2605–2611

    Article  PubMed  Google Scholar 

  6. Reeves BC, Ascione R, Chamberlain MH, Angelini GD (2003) Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol 42:668–676

    Article  PubMed  Google Scholar 

  7. Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471–2477

    Article  CAS  PubMed  Google Scholar 

  8. Maeno K, Kasai T, Kasagi S, Kawana F, Ishiwata S, Ohno M, Yamaguchi T, Narui K (2013) Relationship between atrial conduction delay and obstructive sleep apnea. Heart Vessels 28:639–645

    Article  PubMed  Google Scholar 

  9. Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S (2010) Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123:646–651

    Article  PubMed  Google Scholar 

  10. Ardestani A, Hoffman HJ, Cooper HA (2010) Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 106:369–373

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wang J, Yang YM, Zhu J, Zhang H, Shao XH, Tian L, Huang B, Yu LT, Gao X, Wang M (2014) Overweight is associated with improved survival and outcomes in patients with atrial fibrillation. Clin Res Cardiol 103:533–542

    Article  PubMed  Google Scholar 

  12. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375

    Article  CAS  Google Scholar 

  13. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 163:427–436

    Article  PubMed  PubMed Central  Google Scholar 

  14. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL (1998) The effect of age on the association between body-mass index and mortality. N Engl J Med 338:1–7

    Article  CAS  PubMed  Google Scholar 

  15. Jensen GL (2005) Obesity and functional decline: epidemiology and geriatric consequences. Clin Geriatr Med 21:677–687

    Article  PubMed  Google Scholar 

  16. Matsuzawa Y, Inoue S, Ikeda Y, Sakata T, Saito Y, Sato Y, Shirai A, Ohno M, Miyazaki S, Tokunaga K, Fukagawa K, Yamanouchi K, Nakamura T (2000) Atarashii himan no hantei to himanshou no shindan kijun (New diagnostic criteria for obesity and obesity disease). J Japan Soc Study Obesity 6:18–28 [in Japanese]

    Google Scholar 

  17. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S (2002) Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr 11:S732–S737

    Article  Google Scholar 

  18. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870

    Article  CAS  PubMed  Google Scholar 

  19. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272

    Article  PubMed  Google Scholar 

  20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992

    Article  CAS  Google Scholar 

  21. Suzuki S, Sagara K, Otsuka T, Kano H, Matsuno S, Takai H, Uejima T, Oikawa Y, Koike A, Nagashima K, Kirigaya H, Yajima J, Tanabe H, Sawada H, Aizawa T, Yamashita T (2013) Effects of smoking habit on the prevalence of atrial fibrillation in Japanese patients with special reference to sex differences. Circ J 77:2948–2953

    Article  PubMed  Google Scholar 

  22. Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Lip GY, Larsen TB (2013) Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med 126:640.e9–e17

    Article  Google Scholar 

  23. Murray DR, Freeman GL (2003) Proinflammatory cytokines: predictors of a failing heart? Circulation 107:1460–1462

    Article  PubMed  Google Scholar 

  24. Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D (2010) Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 7:438–444

    Article  PubMed  Google Scholar 

  25. Soeki T, Bando S, Uematsu E, Matsuura T, Niki T, Ise T, Kusunose K, Hotchi J, Ueda Y, Tomita N, Yamaguchi K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M (2014) Pentraxin 3 is a local inflammatory marker in atrial fibrillation. Heart Vessels 29:653–658

    Article  PubMed  Google Scholar 

  26. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96:526–534

    Article  CAS  PubMed  Google Scholar 

  27. Heineke J, Auger-Messier M, Xu J, Sargent M, York A, Welle S, Molkentin JD (2010) Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation 121:419–425

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Workman AJ (2010) Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 381:235–249

    Article  CAS  PubMed  Google Scholar 

  29. Dorner TE, Rieder A (2012) Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 155:56–65

    Article  PubMed  Google Scholar 

  30. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW (1999) Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277:E971–E975

    CAS  PubMed  Google Scholar 

  31. Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC (2007) Medical therapies and invasive treatments for coronary artery disease by body mass: the “obesity paradox” in the Get With The Guidelines database. Am J Cardiol 100:1331–1335

    Article  PubMed  Google Scholar 

  32. Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P (2012) Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 345:e4439

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, Ashley E, West E, Forman DE, Guazzi M, Arena R (2013) Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 88:251–258

    Article  PubMed  Google Scholar 

  34. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T (2008) Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 52:605–615

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuya Inden.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yanagisawa, S., Inden, Y., Yoshida, N. et al. Body mass index is associated with prognosis in Japanese elderly patients with atrial fibrillation: an observational study from the outpatient clinic. Heart Vessels 31, 1553–1561 (2016). https://doi.org/10.1007/s00380-015-0765-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-015-0765-y

Keywords

Navigation